Psoriasis Clinical Trial
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Summary
This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will be collected during the first 3 weeks of the study; safety and efficacy data will be collected for the 8 weeks of the treatment.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of chronic plaque psoriasis
10 - 35% BSA of involved skin
Age 12 - 17
Exclusion Criteria:
Other type of psoriasis (other than plaque)
Significant abnormal lab findings
Vit D insufficiency
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 7 Locations for this study
Little Rock Arkansas, 72205, United States
San Diego California, 92123, United States
Eagan Minnesota, 55121, United States
Houston Texas, 77030, United States
Webster Texas, 77598, United States
St. John's Newfoundland and Labrador, A1B 3, Canada
St. John's Newfoundland and Labrador, A1C 2, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.